Prevention & Chronic Conditions

Broadcast

e-SPACE CRM 2026 – Day Two

Shelley Zieroth, Shahzeb Khan, João Pedro Ferreira

Broadcast

e-SPACE CRM 2026 – Day One

Shelley Zieroth, Shahzeb Khan, João Pedro Ferreira

About

Cardiovascular disease (CVD) is a significant and ever-growing problem in the UK, accounting for nearly one-third of all deaths and leading to significant morbidity. Globally CVD accounts for 31% of mortality, mainly from heart disease and cerebrovascular accident.

The burden of CVD can be ameliorated by careful risk modification and primary prevention is an important priority for all developers of health policy. Strong consensus exists between international guidelines regarding the necessity of smoking cessation, weight optimisation and exercise, although guidelines have slightly different approaches to hypertension and vary considerably regarding their approach to optimal lipid profile, which remains a contentious issue.

Articles

Current Thinking in Acute Congestive Heart Failure and Pulmonary Edema

Citation:

US Cardiology 2004;1(1):1-6

Improving the Quality of Care Following an Acute Cardiac Event

Citation:

US Cardiology 2009;6(2):79–82

Dynamic Bi-level Positive Airway Pressure Ventilation for the Treatment of Central Sleep Apnoea in Patients with Chronic Heart Failure

Citation:

European Cardiovascular Disease 2006;2(1):106

Cardiac Rehabilitation - An Effective and Comprehensive but Underutilized Program to Reduce Cardiovascular Risk in Patients with CVD

Citation:

US Cardiology 2006;3(2):1–4